ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,084Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1290

$971K Total Retail Price of All Prescriptions

Rank: 55 out of 1290

462 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 17,480 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,030 975 1 1
OMEPRAZOLE 645 619 2 2
METFORMIN HCL 491 469 3 10
AMLODIPINE BESYLATE 479 467 4 3
ATENOLOL 423 414 5 18
ATORVASTATIN CALCIUM 423 415 5 23
LOSARTAN POTASSIUM 409 393 7 19
CRESTOR 367 334 8 17
DIOVAN 334 320 9 53
METOPROLOL SUCCINATE 329 323 10 14
LEVOTHYROXINE SODIUM 317 311 11 4
JANUVIA 306 306 12 82
HYDROCHLOROTHIAZIDE 304 295 13 20
FUROSEMIDE 288 278 14 9
METOPROLOL TARTRATE 284 284 15 7
FENOFIBRATE 278 240 16 98
NEXIUM 272 261 17 34
BENICAR 263 258 18 205
LORAZEPAM 246 243 19 132
LISINOPRIL 244 222 20 5
WARFARIN SODIUM 233 216 21 22
TEMAZEPAM 233 229 21 71
CARVEDILOL 221 216 23 12
GLIPIZIDE ER 218 214 24 206
HYDRALAZINE HCL 215 203 25 133
TRAMADOL HCL 205 200 26 25
CLOPIDOGREL 202 196 27 24
POTASSIUM CHLORIDE 195 195 28 35
ESCITALOPRAM OXALATE 188 183 29 63
LOVASTATIN 184 184 30 45
ALENDRONATE SODIUM 176 176 31 39
ENALAPRIL MALEATE 168 168 32 62
JANUMET 167 155 33 217
PLAVIX 163 158 34 32
DONEPEZIL HCL 160 160 35 13
PANTOPRAZOLE SODIUM 156 156 36 48
CLONIDINE HCL 156 156 36 66
ZOLPIDEM TARTRATE 154 154 38 15
RANITIDINE HCL 147 143 39 49
CLONAZEPAM 140 140 40 170
GABAPENTIN 138 124 41 8
SYNTHROID 132 132 42 28
MICARDIS 129 126 43 439
BENICAR HCT 128 120 44 241
DOXAZOSIN MESYLATE 124 117 45 64
DIGOXIN 122 115 46 51
LANTUS 121 121 47 67
TAMSULOSIN HCL 120 120 48 11
LABETALOL HCL 120 107 48 217
MECLIZINE HCL 120 117 48 159
GLYBURIDE 111 111 R 51 87
INSULIN SYRINGE 105 105 52 76
NIFEDIPINE ER 103 99 53 110
AZITHROMYCIN 97 93 54 61
PAROXETINE HCL 97 97 54 84
IBANDRONATE SODIUM 92 82 56 290
IBUPROFEN 89 89 57 74
ACTONEL 87 75 58 207
DIOVAN HCT 86 80 59 112
NADOLOL 86 86 59 423
TEKTURNA 84 82 61 426
FAMOTIDINE 82 82 62 128
RAMIPRIL 80 80 63 136
FOLIC ACID 79 79 64 188
ALPRAZOLAM 77 74 65 47
NAMENDA 77 77 65 27
LANSOPRAZOLE 76 62 67 181
NATEGLINIDE 75 75 68 280
MELOXICAM 75 68 68 31
IRBESARTAN 64 64 70 501
CITALOPRAM HBR 63 63 71 29
NIFEDICAL XL 63 63 71 333
CLOTRIMAZOLE-BETAMETHASONE 63 63 71 153
NITROGLYCERIN PATCH 61 61 74 212
PREDNISONE 60 47 75 21
DICLOFENAC SODIUM 60 60 75 77
ALLOPURINOL 58 57 77 60
MICARDIS HCT 57 57 78 611
AVAPRO 57 57 78 611
ISOSORBIDE MONONITRATE ER 57 57 78 58
FELODIPINE ER 57 57 78 369
LYRICA 55 54 82 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 82 92
CEFUROXIME 54 53 84 420
GLIPIZIDE XL 54 54 84 381
BONIVA 54 54 84 359
SOTALOL 53 53 87 226
BENAZEPRIL HCL 53 53 87 140
LEXAPRO 51 51 89 173
FINASTERIDE 50 50 90 40
DILTIAZEM 24HR CD 50 50 90 315
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.